[1] Eggenhofer E, Steinmann JF, Renner P, et al. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.Transplant Immunol.2011;24(3):157-163.
[2] Li Lin, Tian Hui, Yue Weiming, et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol.2011;226(7):1860-1867.
[3] Wu KH, Chan CK, Tsai C, et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cordderived mesenchymal stem cells. Transplantation. 2011; 91: 1412-1416.
[4] Chen A, Siow B, Blamire AM,et al.Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res.2010;5(3):255-266.
[5] Lim JY, Park SI, Kim SM, et al.Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and-catenin phosphorylation and following transplantation into the ceveloping brain. Cell Transplant.2011;11(12):1855-1866.
[6] da Silva Meirelles L, Chagastelles PC, et al. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci.2006; 119(Pt11): 2204-2213.
[7] Krampera M, Sartoris S, Liotta F, et al. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells.2007;16(5):797-810.
[8] Tsai MS, Hwang SM, Chen KD, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells.2007;25(10):2511-2523.
[9] Fridenshte?n AIa, Piatetski?-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. Arkh Anat Gistol Embriol.1969; 56: 3-11.
[10] Stolzing A,Jones E,McGonagle D,et al.Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev.2008; 129(3): 163-173.
[11] Meyer T, Pfeifroth A, Höcht B.Isolation and characterisation of mesenchymal stem cells in Wharton's jelly of the human umbilical cord: potent cells for cell-based therapies in paediatric surgery?Eur Surg.2008;40(5):239-244.
[12] Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K,et al. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med.2007;10(4):467-473.
[13] Müller I, Kordowich S, Holzwarth C, et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.Blood Cells Mol Dis.2008;40(1):25-32.
[14] Troyer DL,Weiss ML. Wharton’s jelly-derived cell are a primitive stromal cell population. Stem cell.2008; 26(3): 591-599.
[15] Venkataramana NK, Kumar SK, Balaraju S, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res.2010 ;155(2):62-70.
[16] Wang D, Zhang F, Shen W, et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol.2011;152(3): 314-320.
[17] Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med.2007;10(4):459-466.
[18] Mohyeddin-Bonab M,Mohamad-Hassani MR,et al.Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med. 2007 ;10(4):467-473.
[19] Song H, Cha MJ, Song BW, et al.Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells.2010; 28(3): 555-563.
[20] 雷鑫,陈彦,张建林,等.评价脐带间充质干细胞移植前细胞活性的指标[J].中国组织工程研究,2013,17(32):5847-5854.
[21] Sarugaser R, Lickorish D, Baksh D,et al.Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells.2005;23(2): 220-229.
[22] Chen Y, Yu B, Xue G, et al. Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation. Cell Transplant.2013;22(6):1075-1086.
[23] Sohn HS, Heo JS, Kim HS, et al. Duration ofin vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation.Cytotherapy. 2013; 15: 460-466.
[24] Lane TA, Garls D, Mackintosh E, et al. Liquid storage of marrow stromal cells. Transfusion. 2009; 49(7): 1471-1481.
[25] Pal R, Hanwate M, Totey SM. Totey, Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J Tissue Eng Regen Med. 2008;2(7):436-444.
[26] Cramer C, Freisinger E, Jones RK,et al. Persistent High Glucose Concentrations Alter the Regenerative Potential of Mesenchymal Stem Cells. Stem Cells.2010;19(12): 1875-1884.
[27] Schop D, Janssen FW, van Rijn LD,et al.Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng Part A.2009 ;15(8):1877-1886.
[28] Stolzing A,Coleman N,Scutt A.Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res. 2006;9(1):31-35.
[29] Matejtschuk P, Dash CH, Gascoigne EW.Production of human albumin solution: a continually developing colloid. Br J Anaesth.2000;85(6):887-895.
[30] Javazon EH, Beggs KJ , Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol.2004; 32(5):414-425.
[31] Karlsson HL.The comet assay in nanotoxicology research. Anal Bioanal Chem.2010; 398(2): 651-666. |